Photograph of Magdalena O. Cilella, Ph.D.

Education

  • Augustana College, B.A. Biology and Pre-Medicine (1997) cum laude
  • Loyola University Chicago Stritch School of Medicine, Ph.D. Pharmacology and Experimental Therapeutics (2002)

Admissions

  • U.S. Patent and Trademark Office (USPTO)

Professional Experience

  • Loyola University Chicago
    Teaching Fellow, 20002002
    Principles of Pharmacology (graduate level course)

Languages

  • Polish
  • Russian

Magdalena O. Cilella, Ph.D.

Patent Agent
Chicago
mcilella@crowell.com
Phone: +1 312.245.5398
455 N. Cityfront Plaza Drive
Suite 3600
Chicago, IL 60611

Dr. Magdalena Cilella focuses on patent law matters related to molecular/cell biology, pharmaceuticals and biotechnology. Specifically, Magda has assisted clients with preparation and prosecution of patent applications relating to variety of technologies, including diagnostics, proteins, pharmaceuticals and cosmeceuticals, cell-based assays, plants and medical devices.

Magda brings to the firm a strong research background including experiences in neurodegeneration and tauopathies, specializing in intransglutaminase-induced cross-linking in progressive supranuclear palsy and the effects of Echinacea (over-the-counter dietary supplement) on the human immune system.



Recognition

  • Student Speaker Representative, Chicago Chapter for Neuroscience Annual Scientific Meeting, Loyola University Chicago, 2001
  • Arthur J. Schmitt Dissertation Fellowship for outstanding academic achievements and in recognition of the scholarly promise of the proposed dissertation research, 2000
  • Great Lakes Chapter/American Society for Pharmacology and Experimental Therapeutics, 3rd place award (poster presentation), 2000


Affiliations

  • Society for Neuroscience
  • American Society for Pharmacology and Experimental Therapeutics
  • American Association for the Advancement of Science
  • Intellectual Property Owners Association


Publications

  • "Transglutaminase-Induced Cross-Linking of Tau Proteins in Progressive Supranuclear Palsy," co-author, J Neuropath Exp Neurol. 59(11), November 2000, pgs 983-9 (November 1, 2003). Author: Magdalena O. Cilella, Ph.D.
  • "Transglutaminase Enzyme Activity and Expression of Transglutaminase 1 are increased in Progressive Supranuclear Palsy," co-author, J Neuropath Exp Neurol,"62(2), February 2003, pgs 173-84 (February 1, 2003). Author: Magdalena O. Cilella, Ph.D.